Hijery ny anatiny

Hématologie

Gestion et optimisation de l’hémostase

Facteur VII activé recombinant (rFVIIa)

Effective hemostasis with rFVIIa treatment in two patients with severe thrombocytopenia and life-threatening hemorrhage. (manokatra rohy)

Gerotziafas GT, Zervas C, Gavrielidis G, Tokmaktsis A, Hatjiharissi E, Papaioannou M, Lazaridou A, Constantinou N, Samama MM, Christakis J.

Loharanon-kevitra‎: Am J Hematol 2002;69(3):219-22.

Rakitra‎: PubMed 11891811

https://www.ncbi.nlm.nih.gov/pubmed/11891811 (manokatra rohy)

Life-threatening retro-pharyngeal bleed in a case of systemic lupus erythematosus--an uncommon but important evil of a common disease. (manokatra rohy)

Palla A, Rogers J, Singh S.

Loharanon-kevitra‎: BMJ Case Rep 2011;2011:bcr0820114627.

Rakitra‎: PubMed 22675012

DOI‎: 10.1136/bcr.08.2011.4627

https://www.ncbi.nlm.nih.gov/pubmed/22675012 (manokatra rohy)

Experiences with recombinant FVIIa in the emergency treatment of patients with autoimmune thrombocytopenia: a review of the literature. (manokatra rohy)

Salama A, Rieke M, Kiesewetter H, von Depka M.

Loharanon-kevitra‎: Ann Hematol 2009;88(1):11-5.

Rakitra‎: PubMed 18787824

DOI‎: 10.1007/s00277-008-0608-3

https://www.ncbi.nlm.nih.gov/pubmed/18787824 (manokatra rohy)